Sarepta Therapeutics, Inc. (BMV:SRPT)

Mexico flag Mexico · Delayed Price · Currency is MXN
430.00
+12.00 (2.87%)
At close: Oct 9, 2025
2.87%
Market Cap40.07B
Revenue (ttm)46.80B
Net Income (ttm)-1.09B
Shares Outn/a
EPS (ttm)-11.29
PE Ration/a
Forward PE12.97
Dividendn/a
Ex-Dividend Daten/a
Volume24,354
Average Volume3,087
Open439.00
Previous Close418.00
Day's Range430.00 - 441.00
52-Week Range198.74 - 2,501.45
Betan/a
RSI56.96
Earnings DateNov 5, 2025

About Sarepta Therapeutics

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 1,372
Stock Exchange Mexican Stock Exchange
Ticker Symbol SRPT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.